DAVID J SCHEIDERER
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- ROANOKE, VA
- NPI
- 1699978221
- Received
- $2,395,191 in 2,425 records, 2019 to 2025 ($2,381,854 general, $13,337 research)
- As principal investigator
- $26,770 of research payments to others in 5 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 403 | $508,360 |
| 2024 | General payment | 357 | $430,559 |
| 2023 | General payment | 341 | $391,378 |
| 2022 | General payment | 364 | $368,042 |
| 2021 | General payment | 285 | $254,962 |
| 2020 | General payment | 246 | $182,265 |
| 2019 | General payment | 428 | $246,285 |
| 2019 | Research payment | 1 | $13,337 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 571 | $672,333 | 2021–2025 |
| Otsuka America Pharmaceutical, Inc. | 556 | $553,954 | 2019–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 427 | $495,838 | 2020–2025 |
| Axsome Therapeutics, Inc. | 215 | $227,247 | 2022–2025 |
| Allergan, Inc. | 350 | $197,936 | 2019–2021 |
| Alkermes, Inc. | 121 | $110,614 | 2021–2025 |
| Sunovion Pharmaceuticals Inc. | 53 | $34,260 | 2019–2020 |
| Eisai Inc. | 54 | $33,204 | 2020–2022 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 31 | $14,995 | 2019–2025 |
| Eli Lilly and Company | 1 | $13,337 | 2019 |
| Noven Pharmaceuticals, Inc. | 12 | $12,214 | 2020–2021 |
| Vanda Pharmaceuticals Inc. | 11 | $11,522 | 2024–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $9,700 | 2019 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $4,605 | 2023 |
| Merck Sharp & Dohme LLC | 4 | $3,374 | 2022 |
| Neurocrine BioSciences, Inc. | 1 | $30 | 2025 |
| Lundbeck LLC | 1 | $21 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 724 | $1,820,299 |
| Travel and Lodging | 837 | $224,711 |
| Consulting Fee | 65 | $161,289 |
| Honoraria | 58 | $127,661 |
| Food and Beverage | 731 | $45,873 |
| Research payment | 1 | $13,337 |
| Compensation for serving as faculty or as a speaker for a medical education program | 1 | $1,875 |
| Education | 8 | $144 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-17 | Alkermes, Inc. | $3,060 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-12-17 | Axsome Therapeutics, Inc. | $3,037 | Honoraria | Cash or cash equivalent | Sunosi Drug, Neurology | 2025 | |
| 2025-12-17 | Alkermes, Inc. | $2,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $252 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $107 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $4,752 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $3,456 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Alkermes, Inc. | $30 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-12-08 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-12-05 | Otsuka America Pharmaceutical, Inc. | $189 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-05 | Otsuka America Pharmaceutical, Inc. | $189 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $150 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $117 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $710 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $710 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $109 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | Alkermes, Inc. | $2,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-11-20 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | Alkermes, Inc. | $121 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,301 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-13 | ABBVIE INC. | $2,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $229 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-12 | Axsome Therapeutics, Inc. | $115 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-12 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-11-11 | Alkermes, Inc. | $3,060 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-11-06 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $2,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $2,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $869 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $251 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $103 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $102 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-06 | ABBVIE INC. | $40 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $122 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-04 | Axsome Therapeutics, Inc. | $3,375 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $102 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | Alkermes, Inc. | $182 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-30 | Alkermes, Inc. | $119 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-29 | Alkermes, Inc. | $3,060 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-10-29 | Alkermes, Inc. | $2,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-10-29 | ABBVIE INC. | $1,755 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $818 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $494 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | ABBVIE INC. | $252 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | ABBVIE INC. | $47 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ABBVIE INC. | $133 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ABBVIE INC. | $43 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | ABBVIE INC. | $531 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | ABBVIE INC. | $1,393 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | ABBVIE INC. | $112 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-21 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-16 | Alkermes, Inc. | $127 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-14 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $682 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $306 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $177 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $56 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | Alkermes, Inc. | $32 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $1,350 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-17 | ABBVIE INC. | $724 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | ABBVIE INC. | $484 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | ABBVIE INC. | $93 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | ABBVIE INC. | $66 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-15 | ABBVIE INC. | $585 | Consulting Fee | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-09 | Vanda Pharmaceuticals Inc. | $2,940 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-08 | Axsome Therapeutics, Inc. | $3,375 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-03 | Axsome Therapeutics, Inc. | $1,012 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $312 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $302 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $207 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $75 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $4,388 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $3,375 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $371 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $4,725 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $4,388 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $596 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $353 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $81 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $222 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $112 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-13 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $5,738 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $600 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $294 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $118 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $84 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-07 | Axsome Therapeutics, Inc. | $11 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6,105 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $2,025 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $198 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-30 | Axsome Therapeutics, Inc. | $27 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $2,025 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $397 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-29 | Axsome Therapeutics, Inc. | $108 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Axsome Therapeutics, Inc. | $5,738 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Axsome Therapeutics, Inc. | $588 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Axsome Therapeutics, Inc. | $73 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-28 | Axsome Therapeutics, Inc. | $40 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $96 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $751 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $391 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $184 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,272 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,392 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $480 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-17 | Axsome Therapeutics, Inc. | $2,362 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $340 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $164 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $113 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $2,025 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $73 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-07 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | Alkermes, Inc. | $2,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $3,375 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-25 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $5,738 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $612 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $304 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $266 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $227 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-23 | Otsuka America Pharmaceutical, Inc. | $4,752 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-19 | Otsuka America Pharmaceutical, Inc. | $223 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | Otsuka America Pharmaceutical, Inc. | $4,752 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | Otsuka America Pharmaceutical, Inc. | $3,456 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | Otsuka America Pharmaceutical, Inc. | $2,808 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-17 | ABBVIE INC. | $1,755 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-17 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-16 | Axsome Therapeutics, Inc. | $4,387 | Honoraria | Cash or cash equivalent | Sunosi Drug, Neurology | 2025 | |
| 2025-06-14 | Otsuka America Pharmaceutical, Inc. | $4,752 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $596 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $177 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $177 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $122 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $4,752 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $177 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $88 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-10 | ABBVIE INC. | $4,095 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-10 | Otsuka America Pharmaceutical, Inc. | $177 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-10 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-07 | Otsuka America Pharmaceutical, Inc. | $406 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | Otsuka America Pharmaceutical, Inc. | $1,402 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | Otsuka America Pharmaceutical, Inc. | $108 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $122 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-04 | Alkermes, Inc. | $34 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-05-28 | Alkermes, Inc. | $3,060 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-05-28 | ABBVIE INC. | $2,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 |
The latest 200 records of 2,425.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2020-01-28 | Eli Lilly and Company | MERIDIEN RESEARCH | $5 | A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | 2020 |
| 2020-01-13 | Eli Lilly and Company | MERIDIEN RESEARCH | $4,000 | A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | 2020 |
| 2019-11-04 | Eli Lilly and Company | MERIDIEN RESEARCH | $21,512 | A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | 2019 |
| 2019-06-28 | Eli Lilly and Company | MERIDIEN RESEARCH | $1,103 | A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | 2019 |
| 2019-06-18 | Eli Lilly and Company | NEUROLOGY CONSULTANTS OF DALLAS PA | $150 | A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Roanoke, VA, county Roanoke County, VA, state Virginia; placed by its city name.
| Measure | Place (city or town) Roanoke, VA | County Roanoke County, VA | State Virginia |
|---|---|---|---|
| Population B01003 | 98,355 | 97,023 | 8,705,170 |
| Population, 2020 census P1 | 100,011 | 96,929 | 8,631,393 |
| Median age B01002 | 38.3 | 43.5 | 39.0 |
| Under 18 B01001 | 22.6% | 19.6% | 21.7% |
| 65 and over B01001 | 17.8% | 22.1% | 16.7% |
| Households B11001 | 43,575 | 39,725 | 3,365,732 |
| Foreign born B05002 | 8.0% | 6.8% | 13.1% |
| Median household income B19013 | $55,378 | $83,709 | $93,170 |
| Median family income B19113 | $71,692 | $104,654 | $115,213 |
| Per capita income B19301 | $36,576 | $45,801 | $50,666 |
| Poverty rate B17001 | 18.3% | 7.3% | 9.9% |
| Unemployment rate B23025 | 5.6% | 2.8% | 4.3% |
| Civilian labor force B23025 | 48,417 | 48,435 | 4,468,236 |
| Mean commute (minutes) B08013 | 19.0 | 21.8 | 27.3 |
| Bachelor's degree or higher B15003 | 30.0% | 37.1% | 42.2% |
| Housing units B25001 | 49,106 | 42,331 | 3,684,756 |
| Owner-occupied B25003 | 52.4% | 75.7% | 67.3% |
| Renters B25003 | 47.6% | 24.3% | 32.7% |
| Median home value B25077 | $190,500 | $286,000 | $383,700 |
| Median gross rent B25064 | $996 | $1,224 | $1,579 |
| White, not Hispanic B03002 | 55.3% | 82.3% | 58.4% |
| Black B03002 | 27.7% | 6.4% | 18.3% |
| Hispanic or Latino B03002 | 9.0% | 4.1% | 11.0% |
| Asian B03002 | 3.1% | 3.7% | 6.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Roanoke, VA.
Comments